Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer

By                  

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 949-955

Spandidos Publications

Access to resources Recommend Favorite

Use of chemo-radiotherapy in locally advanced non-small cell lung cancer

By Novello S.   Le Chevalier T.  

European Journal of Cancer, Vol. 38, Iss. 2, 2002-01 ,pp. : 292-299

Elsevier

Access to resources Recommend Favorite

Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy

By Dang Jun   Li Guang   Ma Lianghua   Diao Rao   Zang Shuang   Han Chong   Zhang Shuo   Yao Lei  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1175-1180

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

By Yanagihara Kazuhiro   Yoshimura Kenichi   Niimi Miyuki   Yasuda Hiroyasu   Sasaki Takahiko   Nishimura Takafumi   Ishiguro Hiroshi   Matsumoto Shigemi   Kitano Toshiyuki   Kanai Masashi   Misawa Akiko   Tada Harue   Teramukai Satoshi   Mio Tadashi   Fukushima Masanori  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 913-918

Springer Publishing Company

Access to resources Recommend Favorite

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 13-20

John Wiley & Sons Inc

Access to resources Recommend Favorite